Related references
Note: Only part of the references are listed.Imaging techniques: new avenues in cancer gene and cell therapy
Z. Saadatpour et al.
CANCER GENE THERAPY (2017)
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Hamed Mirzaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Zinc oxide nanoparticles: Biological synthesis and biomedical applications
Hamed Mirzaei et al.
CERAMICS INTERNATIONAL (2017)
Green tea and its anti-angiogenesis effects
Bahman Rashidi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study
Simon Kjaer Hermansen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
Modulation of miR-21 signaling by MPS1 in human glioblastoma
Uday B. Maachani et al.
ONCOTARGET (2016)
PiggyBac as a novel vector in cancer gene therapy: current perspective
H. Mirzaei et al.
CANCER GENE THERAPY (2016)
Mesenchymal stem cell: a new horizon in cancer gene therapy
M. Mohammadi et al.
CANCER GENE THERAPY (2016)
Can curcumin and its analogs be a new treatment option in cancer therapy?
H. Mirzaei et al.
CANCER GENE THERAPY (2016)
Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia
S. Fathullahzadeh et al.
CANCER GENE THERAPY (2016)
Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma
M. Mohammadi et al.
CANCER GENE THERAPY (2016)
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
L. Saadatpour et al.
CANCER GENE THERAPY (2016)
Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy
Hamid Reza Mirzaei et al.
CANCER LETTERS (2016)
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Reza Salarinia et al.
CURRENT CANCER DRUG TARGETS (2016)
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
Hamed Mirzaei et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
Hamed Mirzaei et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Hamid Reza Mirzaei et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Curcumin: A new candidate for melanoma therapy?
Hamed Mirzaei et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Boron neutron capture therapy: Moving toward targeted cancer therapy
Hamid Reza Mirzaei et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
SiRNA and epigenetic aberrations in ovarian cancer
Hamed Mirzaei et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity
Hamed Mirzaei et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2016)
Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations
Kai Qu et al.
ONCOTARGET (2016)
Inhibition of miR-21 in glioma cells using catalytic nucleic acids
Agnieszka Belter et al.
SCIENTIFIC REPORTS (2016)
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
Pratheesh Sathyan et al.
JOURNAL OF NEUROSCIENCE (2015)
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
Huilin Shao et al.
NATURE COMMUNICATIONS (2015)
Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients
Rui Shi et al.
ONCOTARGET (2015)
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21
Simona Taverna et al.
ONCOTARGET (2015)
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1
Kiran Kumar Velpula et al.
Oncotarget (2015)
MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3)
Chuan He Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression
Zhendong Shi et al.
CANCER RESEARCH (2013)
Therapeutic Strategies Targeting Glioblastoma Stem Cells
Estefania Carrasco-Garcia et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2013)
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Giridhar Mudduluru et al.
BIOSCIENCE REPORTS (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells
Felix Oppel et al.
MOLECULAR CANCER (2011)
Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
Marta M. Alonso et al.
PLOS ONE (2011)
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Rosaria Maria Rita Gangemi et al.
STEM CELLS (2009)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Share Paper
